Status:
COMPLETED
RFA for GIM Treatment
Lead Sponsor:
King Chulalongkorn Memorial Hospital
Conditions:
Gastric Intestinal Metaplasia
Treatment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Use radiofrequency ablation (RFA) for Gastric intestinal metaplasia (GIM) treatment.
Detailed Description
Gastric intestinal metaplasia (GIM) is a pre-malignant lesion. Currently, there is no standard treatment for this condition, thus the patients with GIM need surveillance endoscopy every 1-3 years, reg...
Eligibility Criteria
Inclusion
- More than 18 years of age
- Previous diagnose of extensive or incomplete GIM
Exclusion
- No GIM at first endoscopy
- Previous gastric surgery
- Coagulopathy
- Pregnancy or lactation
- Unable to perform appropriate peri-procedural cessation of antiplatelet/antithrombotic therapy
- Unable to sign the consent
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04348266
Start Date
June 1 2020
End Date
May 31 2023
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rapat Pittayanon
Pathum Wan, Bangkok, Thailand, 10330